Hikma Pharmaceuticals (LSE:HIK) Price Target Increased by 9.63% to 2,311.15

The average one-year price target for Hikma Pharmaceuticals (LSE:HIK) has been revised to 2,311.15 / share. This is an increase of 9.63% from the prior estimate of 2,108.15 dated August 1, 2023. The price target is an average of many targets provided by analys https://www.nasdaq.com/articles/hikma-pharmaceuticals-lse:hik-price-target-increased-by-9.63-to-2311.15